SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : DNAG - DNAPrint Genomics
DNAG 0.000001000-90.0%May 21 3:43 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jmhollen who started this subject10/1/2002 12:42:35 PM
From: jmhollen   of 409
 
New DNAPrint Testing Service Featured in the New York Times

SARASOTA, Fla.--(BUSINESS WIRE)--Oct. 1, 2002--DNAPrint genomics, Inc. (OTCBB:DNAP) (the "Company") announced that its newly introduced ANCESTRYbyDNA service was featured today in a New York Times article.


The article was published in today's edition: "For Sale: A DNA Test to Measure Racial Mix," authored by Nicholas Wade. DNAP will add the article to its corporate website (http://www.dnaprint.com) later today. Details on the test's utility and exceptional accuracy, as well as new validation data, can be found at ancestrybydna.com.

About ancestrybydna

ANCESTRYbyDNA 2.0 is a new genetic test for the determination of Biogeographical Ancestry (BGA) or ancestral proportions within individuals. Specifically, the test reveals the proportional extent to which a customer is of European, Native American, African, East Asian, South/Middle Asian and/or Pacific Islander genetic heritage. Being a pan-genome test, it is the first of its kind ever developed. Its development was made possible through innovative mathematics and recent advancements in our understanding of the human genome. Information on how to order the test can be found at ancestrybydna.com.

DNAPrint genomics, Inc.

DNAPrint genomics, Inc. develops complex genetic analytics and information resource products for an individualization of drug prescription and advancement of forensic science. The company's products provide practitioners of genomics-based medicine and forensics with a comprehensive system for complex trait dissection and patient/subject classification. This work has real-life application to the germinating fields of Personalized Medicine and Qualitative Forensics, and helps to lay the foundation for a brand-new area of medical research called Phenomics. DNAPrint genomics Inc. was founded in 2000 by a group of scientists with 57 total years of research and commercial experience in high-level mathematical modeling, programming and molecular genetics. The company is traded on the OTCBB and currently employs 14 people, 9 of who are Ph.D.s in Computer Science, Molecular Genetics, Statistics and/or Mathematics. (http://www.dnaprint.com)

CONTACT: DNAPrint genomics, Inc., Sarasota
Carrie Castillo, 941/366-3400
castillo@dnaprint.com

.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext